Discover the fascinating history of Disneyland's Matterhorn and what once existed in its place. Uncover the stories and ...

Results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s (AZN) Imfinzi in combination with ...

If you had to pick the most mountainy-looking mountain in the world, you could do much worse than choose the Matterhorn. Switzerland's most famous peak soars above the surrounding glaciers to a ...

The Matterhorn is surely the world’s most iconic peak. Its commanding, isolated position at the head of the valley is unique in the Alps and its claim to being one of the world’s most beautiful ...

Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

Swiss Mountaineer Dani Arnold breaks the record for the quickest ascent of the north face of the Matterhorn mountain in the Alps. The 1,100 meter-high climb usually takes mountain climbers between ...

Imfinzi is one of AstraZeneca’s key growth drivers for 2025, with potential approvals in stomach and bladder cancers. The ...

AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...